{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":39,"n_cols":5,"rows_kept":39,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[11,4,11,5],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[15,2,15,3],[17,2,17,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[34,2,34,3],[35,2,35,3],[37,2,37,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990002116000403321"]
[null,null,"Autore",null,"Riahi Belkaoui, Ahmed <1943- >"]
[null,null,"Titolo",null,"Advanced management accounting / Ahmed Riahi-Belkaoui"]
[null,null,"Pubbl/distr/stampa",null,"Westport : Quorum Books, 2001"]
[null,null,"ISBN",null,"1-56720-343-4"]
[null,null,"Descrizione fisica",null,"xiv, 321 p. ; 24 cm"]
[null,null,"Locazione",null,"DAGEA"]
[null,null,"Collocazione",null,"62 658.15 RIA"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910805576803321"]
[null,null,"Autore",null,"Lam Jenny"]
[null,null,"Titolo",null,"Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines / / edited by Jenny Lam, Philip Chi Lip Kwok"]
[null,null,"Pubbl/distr/stampa",null,"Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023"]
[null,null,"ISBN",null,"9783031475672"]
[{"$nulls":4},"3031475674"]
[null,null,"Edizione",null,"[1st ed. 2023.]"]
[null,null,"Descrizione fisica",null,"1 online resource (224 pages)"]
[null,null,"Collana",null,"AAPS Introductions in the Pharmaceutical Sciences, , 2522-8358 ; ; 8"]
[null,null,"Disciplina",null,"615.19"]
[null,null,"Soggetti",null,"Pharmaceutical chemistry"]
[{"$nulls":4},"Drug delivery systems"]
[{"$nulls":4},"Biologicals"]
[{"$nulls":4},"Biopharmaceutics"]
[{"$nulls":4},"Vaccines - Biotechnology"]
[{"$nulls":4},"Biomaterials"]
[{"$nulls":4},"Drugs - Design"]
[{"$nulls":4},"Pharmacology"]
[{"$nulls":4},"Pharmaceutics"]
[{"$nulls":4},"Drug Delivery"]
[{"$nulls":4},"Biologics"]
[{"$nulls":4},"Biomaterials-Vaccines"]
[{"$nulls":4},"Structure-Based Drug Design"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Chapter 1: Design strategies of dry powders for pulmonary delivery of pharmaceutical peptides -- Chapter 2. Pulmonary delivery of antibody for the treatment of respiratory diseases -- Chapter 3: Dry powder formulation of monoclonal antibodies for pulmonary delivery -- Chapter 4: Antimicrobial peptides and proteins for inhalation -- Chapter 5: Pulmonary delivery of nucleic acids -- Chapter 6: Intranasal and inhaled vaccines -- Chapter 7: Respiratory delivery of probiotics to improve lung health -- Chapter 8: Respiratory delivery of bacteriophages for the treatment of lung infections -- Chapter 9: Pharmacokinetics of inhaled medications – what do we know about biological macromolecules?."]
[null,null,null,"Sommario/riassunto","Therapeutic macromolecules and biologics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these therapeutic modalities, which have poor oral bioavailability, could constitute an attractive, non-invasive alternative to parenteral delivery. They can be considered for either topical use for treating diseases affecting the airways or for systemic use for treating a variety of other diseases. Therefore, this book is a readable, thoughtful, and useful guide on the latest research developments and the best options that people involved with pulmonary and intranasal route of administration and biologically active agents can bring to their practices. Furthermore, it explores the underlying scientific rationale for the strategies applied to overcome drug delivery challenges and provides insights to inspire further research in this growing area."]